Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPFFR1 | Q9GZQ6 | 4/20 | 0.53 |
| ▸ | NPFFR2 | Q9Y5X5 | 4/20 | 0.53 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.48 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4629996 | 0.84 | CACNA1G (0.55) | NPFFR1NPFFR2CACNA1GOPRM1OPRL1 | |
| SCHEMBL7304297 | 0.84 | NPFFR1 (0.59) | NPFFR1NPFFR2CACNA1GOPRL1ALDH1A1 | |
| SCHEMBL4630028 | 0.83 | CACNA1G (0.54) | NPFFR1NPFFR2CACNA1GOPRM1OPRL1 | |
| SCHEMBL7306023 | 0.83 | CACNA1G (0.52) | NPFFR1NPFFR2CACNA1GOPRM1OPRL1 | |
| SCHEMBL4631201 | 0.82 | BCHE (0.52) | NPFFR1NPFFR2CACNA1GOPRM1OPRL1 | |
| SCHEMBL7305712 | 0.80 | OPRM1 (0.53) | OPRM1OPRL1ALDH1A1KCNA3 | |
| SCHEMBL3937184 | 0.76 | NPFFR1 (0.66) | NPFFR1NPFFR2CACNA1GOPRL1ALDH1A1 | |
| SCHEMBL2842737 | 0.75 | NPFFR1 (0.69) | NPFFR1NPFFR2CACNA1GOPRL1KDM4E | |
| SCHEMBL27566058 | 0.73 | NPFFR1 (0.60) | NPFFR1NPFFR2CACNA1GOPRL1KDM4E | |
| SCHEMBL18423666 | 0.73 | SIGMAR1 (0.74) | OPRM1ALDH1A1KDM4ESIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294537-B1 | NEUROKININS USED FOR TREATMENT OF DISEASES | SANOFI-SYNTHELABO (FR) | 2001-09-25 | — | — | US | disclosed |
| US-6124316-A | ACTIVE DRUG TREATING PSYCHIATRIC DISEASES, DISEASES OF PSYCHOSOMATIC ORIGIN, OF HYPERTENSION AND, NERVOUS SYSTEM DISORDERS | SANOFI (FR) | 2000-09-26 | — | — | US | disclosed |
| US-5942523-A | NOVEL PIPERIDINE DERIVATIVES WHOSE SPECIFIC STRUCTURE INCLUDES AT POSITION 1 AN ALKYL CHAIN HAVING A 3,4-DICHLOROPHENYL GROUP ATTACHED; HIGH SELECTIVITY TO THE NK3 RECEPTOR; UNIT DOSAGE FORM; TREATING PSYCHIATRIC DISEASES | SANOFI (FR) | 1999-08-24 | — | — | US | disclosed |
| US-5741910-A | PIPERIDINE DERIVATIVE INTERMEDIATES | SANOFI (FR) | 1998-04-21 | — | — | US | disclosed |
| EP-0673928-A1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI (FR) | 1995-09-27 | — | — | EP | disclosed |